Evogene
EVGN
16 hedge funds and large institutions have $167K invested in Evogene in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
4.82% less ownership
Funds ownership: 6.32% → 1.5% (-4.8%)
68% less capital invested
Capital invested by funds: $527K → $167K (-$360K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$39.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$26.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$9.21K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.92K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$395K |
| 2 |
Jane Street
New York
|
-$22.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$12.9K |
| 5 |
JP Morgan Chase
New York
|
-$114 |
EVGN Hedge Fund Activity: Q2 2025 in Review
16 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q2 2025, worth a combined $167K — down 68% from $527K a quarter earlier.
Fund positioning in EVGN was balanced in Q2 2025: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $39.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $395K sold.
- 16 institutional investors held Evogene (EVGN) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $167K of Evogene stock for Q2 2025, down 68% quarter-over-quarter.
- 4 funds opened new Evogene positions in Q2 2025 and 4 closed out, a net change of 0 holders.
- The largest Evogene buyer in Q2 2025 was Virtu Financial, an estimated $39.2K added.
- The largest Evogene seller in Q2 2025 was Armistice Capital, an estimated $395K sold.
Based on aggregated 13F filings for Q2 2025.